OTC Stock Market News Today Investing News Show

OTC Stock News

OTC Stock Market News Today

Investing News Show

The October 21, 2014 Money Info OTC Stock Market News Today show featured live interviews with:

Jason Paltrowitz,

Managing Director of Business Development

for

OTC Markets Group

Listen to Part 1 replay of the Show with Jason Paltrowitz interview:

OTC Markets Stock News

OTC Stock News

See website: http://www.otcmarkets.com

and

Rachel Levine Vice President, Investor Relations for

Cleveland BioLabs, Inc.

(NASDAQ Stock Symbol: CBLI)

Corporate Site: cbiolabs.com

Investors Conference Call Transcript — Click Here

Financials News – Click Here

Listen to Part 2 replay of the Show with 

Rachel Levine of Cleveland BioLabs, Inc.

Medical Stocks To Buy CBLI

 

Money Info Show Airs

10 AM to 11 AM EDT

Every Tuesday

Investment News Show

LISTEN LIVE

Use this Link To Watch The Show:

www.princetonresearch.com/money-info-live.htm

Be On The Air With Us
Call In Your Questions
888-792-1590

Jason Paltrowitz, managing director of business development for the OTC Markets Group

OTC Stock News

See website: http://www.otcmarkets.com

See Facebook Page: https://www.facebook.com/OTCMarkets

Jason Paltrowitz is the Managing Director and Global Head of Business Development at OTC Markets Group. Mr. Paltrowitz joined the company on October 2013 after serving more than two years as a Managing Director and Segment Head at JP Morgan Chase & Co. where he managed the custody, clearing and collateral management business in the Corporate and Investment Bank division.

Prior to that, he held several senior management positions at Bank of New York Mellon Corp. Mr. Paltrowitz was also a member of the board of directors at OTC Markets Group from 2008 to 2011 and helped launch the OTCQX marketplace PAL offering for ADR issuers at Bank of New York Mellon.

OTC MARKETS

Three Tiered Marketplaces

The OTC Markets are Open, Transparent and Connected financial marketplaces that provide investors with the information necessary to intelligently analyze, value and trade 10,000 U.S. and global securities through the broker of their choice.

To create clarity in the investment process, we organize these securities into three tiered marketplaces – OTCQX, OTCQB and OTC Pink – based on the quality and quantity of information the companies make available.

OTC Stock Market News

Figures are for October 21, 2014 9:30 EDT

OTCQX Logo

The Best Marketplace

The OTCQX® best marketplace is for established investor-focused U.S. and global companies. To qualify for the OTCQX marketplace, companies must meet high financial standards, demonstrate compliance with U.S. securities laws, be current in their disclosure, and be sponsored by a professional third-party advisor. The companies found on OTCQX are distinguished by the integrity of their operations and diligence with which they convey their qualifications.

 

OTCQB Logo
The Venture Marketplace

The OTCQB® venture marketplace is for entrepreneurial and development stage U.S. and international companies that are unable to qualify for OTCQX. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. These standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors. However, since there are no minimum financial standards other than a $0.01 bid test, companies will vary in their financial strength.

 

OTC Pink Logo
The Open Marketplace

The OTC Pink® marketplace offers trading in a wide spectrum of equity securities through any broker. This marketplace is for all types of companies that are there by reasons of default, distress or design, which is why they are further sub-categorized by the levels of information that they provide.

 

Investment News Show

Listen to the second hour of the show for:

Rachel Levine Vice President, Investor Relations for

Cleveland BioLabs, Inc.

(NASDAQ Stock Symbol: CBLI)

Corporate Site: cbiolabs.com

Investors Conference Call Transcript — Click Here

Financials News – Click Here

Radiation Exposure Treatment Medical Stocks To Buy

 

Cleveland BioLabs (CBLI) Announces

Green Light to Submit

Pre-Emergency Use Authorization Application for Entolimod

Innovative Drugs To Treat Cancer

Buffalo, NY – September 3, 2014 – Cleveland BioLabs, Inc. (NASDAQ:CBLI) today announced that the minutes from its meeting with the U.S. Food and Drug Administration (FDA) in July confirmed that the Company’s existing efficacy and safety data and animal-to-human dose conversion are sufficient to proceed with a pre-Emergency Use Authorization (pre-EUA) submission for entolimod for reducing the risk of death following exposure to potentially lethal irradiation occurring as the result of a radiation disaster.

See more at:

http://www.princetonresearch.com/medical-stock-news-cbli/

Small cap medical stocks

Radiation Exposure Treatment Drugs

Stock News

Just imagine the catastrophe if radioactive material falls into the wrong hands. The Russians have invested heavily in this.  CBLI is involved in the development of Entolimod, which is being developed as radiation countermeasure and a potential cancer treatment, and Curaxin CBL0137, the lead oncology product candidate.

The company conducts business in the United States and in the Russian Federation through our three operating subsidiaries, Incuron, LLC, BioLabs 612, LLC and Panacela Labs, Inc. The company maintains strategic relationships with the Cleveland Clinic, Roswell Park Cancer Institute, and the Children’s Cancer Institute Australia.

To learn more about Cleveland BioLabs, Inc., please visit the Company’s website at http://www.cbiolabs.com.

Cleveland BioLabs (CBLI) Announces

Green Light to Submit

Pre-Emergency Use Authorization Application for Entolimod

See news

Small cap stocks to buy

Stock Market News Today Show

Money Info

The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.

Money Info is hosted by Mike King and Charles Moskowitz.